Regenerative medicine strategies

Anthony Atala

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Applications of regenerative medicine technology may offer novel therapies for patients with injuries, end-stage organ failure, or other clinical problems. Currently, patients suffering from diseased and injured organs can be treated with transplanted organs. However, there is a severe shortage of donor organs that is worsening yearly as the population ages and new cases of organ failure increase. Scientists in the field of regenerative medicine and tissue engineering are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The stem cell field is also advancing rapidly, opening new avenues for this type of therapy. For example, therapeutic cloning and cellular reprogramming may one day provide a potentially limitless source of cells for tissue engineering applications. While stem cells are still in the research phase, some therapies arising from tissue engineering endeavors have already entered the clinical setting successfully, indicating the promise regenerative medicine holds for the future.

Original languageEnglish
Pages (from-to)17-28
Number of pages12
JournalJournal of Pediatric Surgery
Volume47
Issue number1
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Regenerative Medicine
Tissue Engineering
Stem Cells
Cell Engineering
Bioengineering
Cell Transplantation
Therapeutics
Organism Cloning
Tissue Donors
Technology
Wounds and Injuries
Research
Population

Keywords

  • Regenerative medicine
  • Tissue engineering

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Regenerative medicine strategies. / Atala, Anthony.

In: Journal of Pediatric Surgery, Vol. 47, No. 1, 01.01.2012, p. 17-28.

Research output: Contribution to journalArticle

Atala, Anthony. / Regenerative medicine strategies. In: Journal of Pediatric Surgery. 2012 ; Vol. 47, No. 1. pp. 17-28.
@article{e368737534ad44f9bc4c404162374a27,
title = "Regenerative medicine strategies",
abstract = "Applications of regenerative medicine technology may offer novel therapies for patients with injuries, end-stage organ failure, or other clinical problems. Currently, patients suffering from diseased and injured organs can be treated with transplanted organs. However, there is a severe shortage of donor organs that is worsening yearly as the population ages and new cases of organ failure increase. Scientists in the field of regenerative medicine and tissue engineering are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The stem cell field is also advancing rapidly, opening new avenues for this type of therapy. For example, therapeutic cloning and cellular reprogramming may one day provide a potentially limitless source of cells for tissue engineering applications. While stem cells are still in the research phase, some therapies arising from tissue engineering endeavors have already entered the clinical setting successfully, indicating the promise regenerative medicine holds for the future.",
keywords = "Regenerative medicine, Tissue engineering",
author = "Anthony Atala",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.jpedsurg.2011.10.013",
language = "English",
volume = "47",
pages = "17--28",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Regenerative medicine strategies

AU - Atala, Anthony

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Applications of regenerative medicine technology may offer novel therapies for patients with injuries, end-stage organ failure, or other clinical problems. Currently, patients suffering from diseased and injured organs can be treated with transplanted organs. However, there is a severe shortage of donor organs that is worsening yearly as the population ages and new cases of organ failure increase. Scientists in the field of regenerative medicine and tissue engineering are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The stem cell field is also advancing rapidly, opening new avenues for this type of therapy. For example, therapeutic cloning and cellular reprogramming may one day provide a potentially limitless source of cells for tissue engineering applications. While stem cells are still in the research phase, some therapies arising from tissue engineering endeavors have already entered the clinical setting successfully, indicating the promise regenerative medicine holds for the future.

AB - Applications of regenerative medicine technology may offer novel therapies for patients with injuries, end-stage organ failure, or other clinical problems. Currently, patients suffering from diseased and injured organs can be treated with transplanted organs. However, there is a severe shortage of donor organs that is worsening yearly as the population ages and new cases of organ failure increase. Scientists in the field of regenerative medicine and tissue engineering are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The stem cell field is also advancing rapidly, opening new avenues for this type of therapy. For example, therapeutic cloning and cellular reprogramming may one day provide a potentially limitless source of cells for tissue engineering applications. While stem cells are still in the research phase, some therapies arising from tissue engineering endeavors have already entered the clinical setting successfully, indicating the promise regenerative medicine holds for the future.

KW - Regenerative medicine

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84855822404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855822404&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2011.10.013

DO - 10.1016/j.jpedsurg.2011.10.013

M3 - Article

C2 - 22244387

AN - SCOPUS:84855822404

VL - 47

SP - 17

EP - 28

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 1

ER -